Mixed options sentiment in Novo Nordisk (NVO), with shares down $1.12 near $50.24. Options volume running well above average with 81k contracts traded and calls leading puts for a put/call ratio of 0.55, compared to a typical level near 0.67. Implied volatility (IV30) is higher by 1.2 points near 59.5, in the highest 10% of observations over the past year, suggesting an expected daily move of $1.88. Put-call skew steepened, indicating increased demand for downside protection.Looking ahead: Novo Nordisk (NVO) will report earnings before the open on 2025-11-05.Option markets are pricing in a 50% probability of a move greater than 7.53% or $3.78.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Midday Fly By: Big Tech reports, Novo tops Pfizer bid for Metsera
- M&A War: Pfizer Blasts Rival Novo Nordisk for “Reckless” $8.5B Hijack of Metsera Obesity Deal
- Novo Nordisk Proposes Acquisition of Metsera to Expand Diabetes Portfolio
- Metsera receives unsolicted proposal from Novo Nordisk
- Novo Nordisk offers to buy Metsera for up to $77.75 per share, or $9B